909.9000 -12.00 (-1.30%)
NSE Sep 26, 2025 15:31 PM
Volume: 162.6K
 

BOB Capital Markets Ltd.
Revenue/EBITDA/ PAT grew 6.7%/8% and 19% above our estimates. EBITDA margin reported 20bps above estimates of 15.4% in 4QFY25
Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended